Lipids module 2: cardiovascular risk

Released 14 June 2024     Expires: 14 June 2026      Programme: Lipids 1 CPD/CME credit

Sponsorship Statement: Novartis Pharmaceuticals UK Ltd has provided OmniaMed Communications Ltd with an arm’s length sponsorship towards the update of the BJC e-learning programme in lipids.

Designed to give healthcare professionals an understanding of how to assess and manage cardiovascular risk.

Module first published 9 July 2015
Module first revised 17 March 2021
Second revision June 2024

Learning objectives

Upon completing this module, participants should be better able to:

  • Define the concept of ‘cardiovascular risk factors’
  • Understand the need for risk assessment and screening
  • Utilise ‘risk engines’ and scoring systems
  • Assess which patients to exclude from standard risk assessment

Faculty

Second revision in 2024 by:
Dr Saleem Ansari, Specialist Registrar in Chemical Pathology and Metabolic Medicine; and Lipids and Cardiovascular Risk Service, Department of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust
Dr Jaimini Cegla, Consultant in Chemical Pathology and Metabolic Medicine; and Lipids and Cardiovascular Risk Service, Department of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust
Dr Madhavi Nallagonda, Specialist Registrar in Chemical Pathology and Metabolic Medicine, Imperial College Healthcare NHS Trust, London
Programme editor: Dr Dermot Neely, Heart UK Trustee and Adviser

First revision in 2021 by:
Professor Tim Reynolds, Consultant Chemical Pathologist, University Hospitals of Derby and Burton
Programme editor: Dr Dermot Neely

Original module
Dr Dermot Neely
Dr David Thompson, Clinical Research Fellow, International Centre for Circulatory Health, Imperial College London

Accreditation

1 CPD/CME credit, 1.0 hour
BJC Learning has assigned one hour of CPD/CME credit to this module

Endorsed by:

You need to login to take this module

You need to be a registered member to view this page. It's quick, free and offers you a host of other benefits, including the facility to print and download articles and supplements, access our archived issues and receive email updates when new issues and other content are online.

4 thoughts on “Lipids module 2: cardiovascular risk”

All rights reserved. No part of this programme may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publishers, Medinews (Cardiology) Limited.

It shall not, by way of trade or otherwise, be lent, re-sold, hired or otherwise circulated without the publisher’s prior consent.

Medical knowledge is constantly changing. As new information becomes available, changes in treatment, procedures, equipment and the use of drugs becomes necessary. The editors/authors/contributors and the publishers have taken care to ensure that the information given in this text is accurate and up to date. Readers are strongly advised to confirm that the information, especially with regard to drug usage, complies with the latest legislation and standards of practice.

Healthcare professionals should consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews (Cardiology) Limited cannot accept responsibility for any errors in prescribing which may occur.